Related references
Note: Only part of the references are listed.Simultaneous HPLC Determination of Metronidazole and Spiramycin in Plasma and Brain of Mouse
Chew W. Kit et al.
Current Pharmaceutical Analysis (2012)
Toxoplasma gondii: Determination of the onset of chronic infection in mice and the in vitro reactivation of brain cysts
Wai Kit Chew et al.
EXPERIMENTAL PARASITOLOGY (2012)
Failure of conventional treatment with pyrimethamine and sulfadiazine for secondary prophylaxis of cerebral toxoplasmosis in a patient with AIDS
Benoit Faucher et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2011)
Metronidazole leads to enhanced uptake of imatinib in brain, liver and kidney without affecting its plasma pharmacokinetics in mice
Shin Yee Tan et al.
JOURNAL OF PHARMACY AND PHARMACOLOGY (2011)
Design of anti-parasitic and anti-fungal hydroxy-naphthoquinones that are less susceptible to drug resistance
Louise M. Hughes et al.
MOLECULAR AND BIOCHEMICAL PARASITOLOGY (2011)
Effect of metronidazole on the pharmacokinetics of fexofenadine, a P-glycoprotein substrate, in healthy male volunteers
Kyoung-Ah Kim et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2010)
Toxoplasmosis as a cause for behaviour disorders - overview of evidence and mechanisms
Abebaw Fekadu et al.
FOLIA PARASITOLOGICA (2010)
Congenital toxoplasmosis: candidate host immune genes relevant for vertical transmission and pathogenesis
L. B. Ortiz-Alegria et al.
GENES AND IMMUNITY (2010)
Migraine Associated with Patent Foramen Ovale May Be Caused by Reactivation of Cerebral Toxoplasmosis Triggered by Arterial Blood Oxygen Desaturation
Joseph Prandota
INTERNATIONAL JOURNAL OF NEUROSCIENCE (2010)
Toxoplasma gondii: determinants of tachyzoite to bradyzoite conversion
Sini Skariah et al.
PARASITOLOGY RESEARCH (2010)
Effects of Drug Transporters on Volume of Distribution
Anita Grover et al.
AAPS JOURNAL (2009)
MOLLARET MENINGITIS MAY BE CAUSED BY REACTIVATION OF LATENT CEREBRAL TOXOPLASMOSIS
Joseph Prandota
INTERNATIONAL JOURNAL OF NEUROSCIENCE (2009)
THE IMPORTANCE OF TOXOPLASMA GONDII INFECTION IN DISEASES PRESENTING WITH HEADACHES. HEADACHES AND ASEPTIC MENINGITIS MAY BE MANIFESTATIONS OF THE JARISCH-HERXHEIMER REACTION
Joseph Prandota
INTERNATIONAL JOURNAL OF NEUROSCIENCE (2009)
Stress-related and spontaneous stage differentiation of Toxoplasma gondii
Marialice da Fonseca Ferreira da Silva et al.
MOLECULAR BIOSYSTEMS (2008)
Roles of P-glycoprotein, Bcrp, and Mrp2 in biliary excretion of spiramycin in mice
Xianbin Tian et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
Does metronidazole interact with CYP3A substrates by inhibiting their metabolism through this metabolic pathway? Or should other mechanisms be considered?
Rhonda Roedler et al.
ANNALS OF PHARMACOTHERAPY (2007)
Parasites as causative agents of human affective disorders?: The impact of anti-psychotic, mood-stabilizer and anti-parasite medication on Toxoplasma gondii's ability to alter host behaviour
JP Webster et al.
PROCEEDINGS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES (2006)
Structural identification of bitespiramycin metabolites in rat: A single oral dose study
XG Shi et al.
XENOBIOTICA (2005)
Effectiveness of spiramycin in murine models of acute and chronic toxoplasmosis
J Grujic et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2005)
Infection of human astrocytes and glioblastoma cells with Toxoplasma gondii:: monocyte chemotactic protein-1 secretion and chemokine expression in vitro
MP Brenier-Pinchart et al.
ACTA NEUROPATHOLOGICA (2004)
Atovaquone maintenance therapy prevents reactivation of toxoplasmic encephalitis in a murine model of reactivated toxoplasmosis
IR Dunay et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2004)
Investigation of probable relationship between Toxoplasma gondii and cryptogenic epilepsy
S Yazar et al.
SEIZURE-EUROPEAN JOURNAL OF EPILEPSY (2003)
Toxoplasma gondii in vitro culture for experimentation
JMW Chatterton et al.
JOURNAL OF MICROBIOLOGICAL METHODS (2002)
Antiparasitic agent atovaquone
AL Baggish et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2002)